References - Therapeutic Strategies in Cancer Biology and Pathology - page 210

Foronjy, R., Imai, K., Shiomi, T., Mercer, B., Sklepkiewicz, P., Thankachen, J., et al., 2010.
The divergent roles of secreted Frizzled related protein-1 (SFRP1) in lung morphogenesis
and emphysema. Am. J. Pathol. 177, 598-607.
Foster, K.G., Acosta-Jaquez, H.A., Romeo, Y., Ekim, B., Soliman, G.A., Carriere, A., et al.,
2010. Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phos-
phorylation. J. Biol. Chem. 285, 80-94.
Fotovati, A., Fujii, T., Yamaguchi, M., Kage, M., Shirouzu, K., Oie, S., et al., 2006. 17 beta-
estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-
related and metastasis suppressor gene, in human breast cancer cells. Clin. Cancer Res.
12, 3010-3018.
Frank-Kamenetsky, M., Zhang, X.M., Bottega, S., Guicherit, O., Wichterle, H., Dudek, H.,
et al., 2002. Small-molecule modulators of Hedgehog signaling: identification and char-
acterization of Smoothened agonists and antagonists. J. Biol. 1, 10-19.
Frankel, L.B., Christoffersen, N.R., Jacobsen, A., Lindow, M., Krogh, A., Lund, A.H., 2008.
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA
miR-21 in breast cancer cells. J. Biol. Chem. 283, 1026-1033.
Fransvea, E., Angelotti, U., Antonaci, S., Giannelli, G., 2008. Blocking transforming growth
factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular
carcinoma cells. Hepatology 47, 1557-1566.
Friess, H., Ding, J., Kleeff, J., Fenkell, L., Rosinski, J.A., Guweidhi, A., et al., 2003.
Microarray-based identification of differentially expressed growth- and metastasis-
associated genes in pancreatic cancer. Cell. Mol. Life Sci. 60, 1180-1199.
Fu, L., Qin, Y.R., Xie, D., Hu, L., Kwong, D.L., Srivastava, G., et al., 2007. Characterisation
of a novel tumour suppressor gene PLC delta 1 at 3p22 in oesophageal squamous cell
carcinoma. Cancer Res. 67, 10720-10726.
Fu, L., Gao, Z., Zhang, X., Tsang, Y.H., Goh, H.K., Geng, H., et al., 2009. Frequent concomi-
tant epigenetic silencing of the stress-responsive tumor suppressor gene CADM1, and its
interacting partner DAL-1 in nasal NK/T-cell lymphoma. Int. J. Cancer 124, 1572-1578.
Fu, Z., Smith, P.C., Zhang, L.Z., Rubin, M.A., Dunn, R.L., Yao, Z., et al., 2003. Effects of Raf
kinase inhibitor protein expression on suppression of prostate cancer metastasis. J. Natl.
Cancer Inst. 95, 878-889.
Fu, Z., Kitagawa, Y., Shen, R.L., Shah, R., Mehra, R., Rhodes, D., et al., 2006. Metastasis sup-
pressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate
cancer. Prostate 66, 248-256.
Fujii, M., Toyoda, T., Nakanishi, H., Yatabe, Y., Sato, A., Matsudaira, Y., et al., 2012. TGF-
beta synergizes with defects in the Hippo pathway to stimulate human malignant meso-
thelioma growth. J. Exp. Med. 209, 479-494.
Fujii, N., You, L., Xu, Z., Uematsu, K., Shan, J., He, B., et al. 2007. An antagonist of
Dishevelled protein-protein interaction suppresses B-catenin-dependent tumor cell
growth. Cancer Res. 67, 573-579.
Fukami, T., Fukuhara, H., Kuramochi, M., Maruyama, T., Isogai, K., Sakamoto, M., et al.,
2003. Promoter methylation of the TSLC1 gene in advanced lung tumors and various
cancer cell lines. Int. J. Cancer 107, 53-59.
Futscher, B.W., Oshiro, M.M., Wozniak, R.J., Holtan, N., Hanigan, C.L., Duan, H., et al.,
2002. Role for DNA methylation in the control of cell type-specific maspin expression.
Nat. Genet. 31, 175-179.
Gadgeel, S., Maitah, M., Ali, S., Lorusso, P., Sarkar, F., 2011. GDC-0449, a Hedgehog (HH)
pathway inhibitor can attenuate epithelial mesenchymal transition (EMT) phenotype
in non-small cell lung cancer (NSCLC) cells and enhance the effcts of Erlotinib and
Cisplatin. J. Thoracic. Oncol. 6, S921.